Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-18-021296
Filing Date
2018-03-22
Accepted
2018-03-22 17:45:36
Documents
1
Period of Report
2018-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4551
  Complete submission text file 0001209191-18-021296.txt   5952
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYNAVAX TECHNOLOGIES CORP 2929 SEVENTH ST STE 100 BERKELEY CA 94710
Business Address
COFFMAN ROBERT (Reporting) CIK: 0001278710 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34207 | Film No.: 18707802